Vanda Pharmaceuticals Rejects Revised Unsolicited Acquisition Proposal From Future Pak, Concluding It Undervalues The Company; Board Unanimously Decides Proposal Is Not In The Best Interests Of Shareholders
Vanda Pharmicals拒絕了Future Pak主動提出的經修訂的收購提案,認爲該提案低估了公司的價值;董事會一致認爲該提案不符合股東的最大利益